"Designing Growth Strategies is in our DNA"

Nebulizers Market Size, Share and Global Trend By Product (Pneumatic Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers, Others), By End User (Clinics, Hospitals, Ambulatory Surgery Centres, Home Care Settings, Others), and Geography Forecast till 2026

Region : Global | Published Date: Upcoming | Report ID: FBI100707| Status : Upcoming



Nebulizer is a medical device which converts the drug into vapor and delivers it directly to the lungs of the patient. The procedure of nebulization is commonly used for the treatment of respiratory diseases including asthma, cystic fibrosis and chronic obstructive pulmonary disease (COPD). Nebulizers aid in the treatment of asthma by the easy administration of large dosages of a variety of medicines, immediate relief, and the convenience of administration of medication to infants and children. According to the of 2016, Global Burden of Disease Study, an estimated 251 million people globally were suffering from Chronic Obstructive Pulmonary Disease (COPD).

Increased prevalence of respiratory disorders such as asthma, chronic obstructive pulmonary disease (COPD) and increasing levels of pollution are some of the factors driving the growth of the global nebulizers market. According to the Centers for Disease Control and Prevention (CDC), chronic obstructive pulmonary disease (COPD) affects about 16 million individuals in the U.S. In statistics published by the Asthma and Allergy Foundation of America (AAFA), 1 in 13 individuals in the U.S. have asthma and that more than 26 million Americans were suffering from asthma.

To get information on various segments, share your queries with us

These trends combined with the other factors are expected to positively drive the growth of the global nebulizers market. Additionally, rise in obesity, sedentary lifestyle, over consumption of tobacco and alcohol leading respiratory disorders. These are some of the anticipated to have more demand for the nebulizers subsequently driving the growth of the global nebulizers market.

The factors limiting the growth of the global nebulizers market are the associated side effects of nebulizers, risk of infections, loss of medications during delivery, the extra time required for administration and difficulties in transportation. 

Key Players Covered

Some of the major companies that are present in the global nebulizers market are OMRON Corporation, Koninklijke Philips N.V., PARI, Becton, Dickinson and Company, Allied Healthcare, Agilent Technologies, Inc., Medline Industries, Inc., and Briggs Healthcare and others.




By Product

· Pneumatic Nebulizers

· Ultrasonic Nebulizers

· Mesh Nebulizers

· Others

By End User

· Clinics

· Hospitals

· Ambulatory Surgery Centres

· Home Care Settings

· Others

By Geography

· North America (USA and Canada)

· Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)

· Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)

· Latin America (Brazil, Mexico and Rest of Latin America)

· Middle East & Africa (South Africa, GCC and Rest of Middle East & Africa)


In 2018, among products, pneumatic nebulizer dominated the global nebulizers market due to the high prevalence of respiratory disorders among aging population. The segment is projected to continue its dominance its market share during the forecast period.

Key Insights

  • Prevalence of Respiratory Disease, By Key Regions
  • Pricing Analysis of Key Players in Major Countries/Regions
  • Technological Advancements
  • Recent Industry Developments Such as Partnerships, Mergers, and Acquisitions

Regional Analysis

North America dominated the global nebulizers market in 2018, due to a number of factors such as the increasing prevalence of respiratory disorders, increasing pollution levels, rise in healthcare expenditure and increased adoption of technologically advanced medical devices. Asia Pacific is anticipated to grow at a significant CAGR during the forecast period due to high pollution levels in countries such as India and China, technological advancements, increasing awareness of diseases and increasing disposable income. Additionally, according to the Institute for Health Metrics and Evaluation, in Japan, chronic obstructive pulmonary disease (COPD) cases registered an increase by 24.2% from 2005 to 2016. The increasing prevalence of the chronic obstructive pulmonary disease (COPD) in Asia Pacific is expected to drive the growth of the global nebulizers market during the forecast period of 2019-2026.

Key Industry Developments

  • In November 2018, Theravance Biopharma, Inc., launched YUPELRI (revefenacin), the first and only once-daily, nebulized bronchodilator approved for the treatment of COPD in the US.
  • In October 2018, Koninklijke Philips N.V., launched of InnoSpire Go, Philips smallest and lightest portable hand-held nebulizer system designed to deliver medication in just four minutes, reducing treatment time by up to 25 percent.

Nebulizers Market Size, Share and Global Industry Trend Forecast till 2026
  • PDF
  • 2018
  • 2014-2017


  • 4850

Healthcare Clients

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . More info.